These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic susceptibility to diabetes in inbred strains of mice: measurements of proinsulin mRNA and response to dexamethasone. Orland MJ, Permutt MA. Diabetologia; 1987 Dec; 30(12):934-9. PubMed ID: 3325325 [Abstract] [Full Text] [Related]
3. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control. Kaku K, Province M, Permutt MA. Diabetologia; 1989 Sep; 32(9):636-43. PubMed ID: 2676665 [Abstract] [Full Text] [Related]
4. Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis. Orland MJ, Chyn R, Permutt MA. J Clin Invest; 1985 Jun; 75(6):2047-55. PubMed ID: 3891788 [Abstract] [Full Text] [Related]
5. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice. Berelowitz M, Coleman DL, Frohman LA. Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273 [Abstract] [Full Text] [Related]
6. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia. Garris DR, Garris BL. Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653 [Abstract] [Full Text] [Related]
7. Comparative modulations of insulin secretion, pancreatic insulin content, and proinsulin mRNA in rats. Effects of 50% pancreatectomy and dexamethasone administration. Orland MJ, Permutt MA. Diabetes; 1991 Feb; 40(2):181-9. PubMed ID: 1991569 [Abstract] [Full Text] [Related]
8. An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes. Permutt MA, Kakita K, Malinas P, Karl I, Bonner-Weir S, Weir G, Giddings SJ. J Clin Invest; 1984 May; 73(5):1344-50. PubMed ID: 6232285 [Abstract] [Full Text] [Related]
9. Impaired insulin biosynthetic capacity in a rat model for non-insulin-dependent diabetes. Studies with dexamethasone. Giddings SJ, Orland MJ, Weir GC, Bonner-Weir S, Permutt MA. Diabetes; 1985 Mar; 34(3):235-40. PubMed ID: 3882490 [Abstract] [Full Text] [Related]
10. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome. Timmers K, Voyles NR, Zalenski C, Wilkins S, Recant L. Diabetes; 1986 Oct; 35(10):1143-51. PubMed ID: 2944783 [Abstract] [Full Text] [Related]
11. Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry. Chen L, Komiya I, Inman L, McCorkle K, Alam T, Unger RH. Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1367-71. PubMed ID: 2645581 [Abstract] [Full Text] [Related]
12. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice. Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, Taiji M. Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397 [Abstract] [Full Text] [Related]
13. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice. Fujiwara T, Wada M, Fukuda K, Fukami M, Yoshioka S, Yoshioka T, Horikoshi H. Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750 [Abstract] [Full Text] [Related]
14. Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice. Kang T, Boland BB, Jensen P, Alarcon C, Nawrocki A, Grimsby JS, Rhodes CJ, Larsen MR. Mol Cell Proteomics; 2020 Jun; 19(6):971-993. PubMed ID: 32265294 [Abstract] [Full Text] [Related]
15. Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus. Halban PA, Bonner-Weir S, Weir GC. Diabetes; 1983 Mar; 32(3):277-83. PubMed ID: 6337906 [Abstract] [Full Text] [Related]
16. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37). Hosokawa YA, Hosokawa H, Chen C, Leahy JL. J Clin Invest; 1996 Jan 01; 97(1):180-6. PubMed ID: 8550831 [Abstract] [Full Text] [Related]
17. Proinsulin I and II gene expression in inbred mouse strains. Koranyi L, Permutt MA, Chirgwin JM, Giddings SJ. Mol Endocrinol; 1989 Nov 01; 3(11):1895-902. PubMed ID: 2608062 [Abstract] [Full Text] [Related]
18. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background. Garris DR, Garris BL. Pathobiology; 2004 Nov 01; 71(5):231-40. PubMed ID: 15459481 [Abstract] [Full Text] [Related]
19. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice. Piercy V, Toseland CD, Turner NC. Metabolism; 2000 Dec 01; 49(12):1548-54. PubMed ID: 11145115 [Abstract] [Full Text] [Related]
20. Differential expression of rat pancreatic islet beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment. Koranyi L, Bourey R, Turk J, Mueckler M, Permutt MA. Diabetologia; 1992 Dec 01; 35(12):1125-32. PubMed ID: 1282477 [Abstract] [Full Text] [Related] Page: [Next] [New Search]